Novastan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
012319972016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
Unfractionated heparin has enjoyed the sole anticoagulant status for almost half a century. Besides an effective anticoagulant… (More)
Is this relevant?
1999
1999
A multicenter clinical trial of the thrombin inhibitor argatroban (Novastan; Texas Biotechnology, Houston, TX; Smith-Kline… (More)
Is this relevant?
1999
1999
Despite the use of potent anticoagulants such as r-hirudin and argatroban, the morbidity/mortality of heparin-induced… (More)
Is this relevant?
Review
1998
Review
1998
From injury through healing, thrombin has several important functions in blood clotting, subsequent clot lysis, and tissue repair… (More)
Is this relevant?
1997
1997
We describe a case of a 70-year-old male who underwent coronary artery bypass surgery which was complicated by multiple… (More)
Is this relevant?
Review
1997
Review
1997
Because of the unsatisfactory options available for safe and effective antithrombotic therapy, recent, intense research and… (More)
Is this relevant?
Review
1997
Review
1997
Heparin-induced thrombocytopenia (HIT) is a syndrome that has been identified with increased frequency. The mortality associated… (More)
Is this relevant?